Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients

Paolo Fiorina, Franco Folli, Elisabetta Ferrero, Elena Orsenigo, Giovanna Finzi, Gabriella Mazzolari, Claudia Placidi, Lucia Perego, Stefano La Rosa, Marco Melandri, Lucilla Monti, Carlo Capella, Armando D'Angelo, Carlo Staudacher, Antonio Secchi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

End-stage renal disease (ESRD) is characterized by several atherothrombotic abnormalities, and kidney transplant seems to improve most of them. However, because it is not clear which mechanism is responsible for such improvement, our purpose was to clarify that point. We conducted a cross sectional study involving 30 ESRD patients, 30 ESRD kidney-transplanted patients (Ktx) and 30 healthy controls (C) to evaluate platelet morphology and function, atherothrombotic profile, endothelial abnormalities and cytokine levels involved in the insulin resistance/endothelial dysfunction. (i) Platelet morphology: The ESRD group showed platelet size similar to the other two groups (ESRD = 3518 × 103 ± 549 × 103 nm2, C = 3075 × 103 ± 197 × 103 nm2, Ktx = 2862 × 103 ± 205 × 103 nm 2) with similar platelet granules and number. (ii) Platelet surface glycoprotein: The CD41 and P-Selectin were similar between groups. (iii) Platelet intracellular calcium: Resting intracellular calcium was statistically higher in ESRD compared to the C group (ESRD = 182.1 ± 34.5, Ktx = 126.7 ± 14.1, C = 72.0 ± 11.0 nM, P < 0.01). (iv) Hypercoagulability markers and natural anticoagulants: The Ktx and ESRD groups showed higher levels of hypercoagulability markers compared to the C group. A reduction in antithrombin activity was evident in ESRD compared to the Ktx group (P = 0.03). (v) Endothelial morphology: The ESRD group showed a thickened vessel basal membrane compared to the Ktx and C groups with more endothelial sufference. (vi) Insulin resistance and pro-inflammatory cytokine profile: The ESRD showed a higher homeostasis model assessment provided equations for estimating insulin resistance (HOMA-IR) compared to the Ktx and C groups (ESRD = 2.6 ± 0.3, Ktx = 1.8 ± 0.2, C = 1.1 ± 0.1, P = 0.005) and increased soluble tumor neurosis factor α (sTNFα) (P < 0.05) and soluble vascular cell adhesion molecule (sVCAM) levels (P < 0.01). Positive correlations were evident among HOMA-IR and sTNFα (P < 0.001) and sVCAM (P = 0.01), respectively. In a small subgroup of ESRD who underwent Ktx (five pts), our findings were confirmed at 1 year of follow-up, suggesting an improvement of almost haemostatic abnormalities. Kidney transplant is associated with a better atherothrombotic profile in ESRD, platelet intracellular calcium and cytokines seem to be most influenced by the transplant, while most morphological abnormalities are retained.

Original languageEnglish (US)
Pages (from-to)1036-1047
Number of pages12
JournalTransplant International
Volume18
Issue number9
DOIs
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Hemostatics
Chronic Kidney Failure
Kidney
Blood Platelets
Insulin Resistance
Thrombophilia
Neurotic Disorders
Vascular Cell Adhesion Molecule-1
Cytokines
Calcium
Transplants
Platelet Membrane Glycoproteins
P-Selectin
Antithrombins
Membrane Glycoproteins
Platelet Count
Anticoagulants
Neoplasms
Homeostasis
Cross-Sectional Studies

Keywords

  • End-stage renal disease
  • Haemostasis
  • Kidney transplant
  • Platelets

ASJC Scopus subject areas

  • Transplantation

Cite this

Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients. / Fiorina, Paolo; Folli, Franco; Ferrero, Elisabetta; Orsenigo, Elena; Finzi, Giovanna; Mazzolari, Gabriella; Placidi, Claudia; Perego, Lucia; La Rosa, Stefano; Melandri, Marco; Monti, Lucilla; Capella, Carlo; D'Angelo, Armando; Staudacher, Carlo; Secchi, Antonio.

In: Transplant International, Vol. 18, No. 9, 09.2005, p. 1036-1047.

Research output: Contribution to journalArticle

Fiorina, P, Folli, F, Ferrero, E, Orsenigo, E, Finzi, G, Mazzolari, G, Placidi, C, Perego, L, La Rosa, S, Melandri, M, Monti, L, Capella, C, D'Angelo, A, Staudacher, C & Secchi, A 2005, 'Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients', Transplant International, vol. 18, no. 9, pp. 1036-1047. https://doi.org/10.1111/j.1432-2277.2005.00173.x
Fiorina, Paolo ; Folli, Franco ; Ferrero, Elisabetta ; Orsenigo, Elena ; Finzi, Giovanna ; Mazzolari, Gabriella ; Placidi, Claudia ; Perego, Lucia ; La Rosa, Stefano ; Melandri, Marco ; Monti, Lucilla ; Capella, Carlo ; D'Angelo, Armando ; Staudacher, Carlo ; Secchi, Antonio. / Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients. In: Transplant International. 2005 ; Vol. 18, No. 9. pp. 1036-1047.
@article{8138e40f999f417292fcc03f8ee9bc47,
title = "Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients",
abstract = "End-stage renal disease (ESRD) is characterized by several atherothrombotic abnormalities, and kidney transplant seems to improve most of them. However, because it is not clear which mechanism is responsible for such improvement, our purpose was to clarify that point. We conducted a cross sectional study involving 30 ESRD patients, 30 ESRD kidney-transplanted patients (Ktx) and 30 healthy controls (C) to evaluate platelet morphology and function, atherothrombotic profile, endothelial abnormalities and cytokine levels involved in the insulin resistance/endothelial dysfunction. (i) Platelet morphology: The ESRD group showed platelet size similar to the other two groups (ESRD = 3518 × 103 ± 549 × 103 nm2, C = 3075 × 103 ± 197 × 103 nm2, Ktx = 2862 × 103 ± 205 × 103 nm 2) with similar platelet granules and number. (ii) Platelet surface glycoprotein: The CD41 and P-Selectin were similar between groups. (iii) Platelet intracellular calcium: Resting intracellular calcium was statistically higher in ESRD compared to the C group (ESRD = 182.1 ± 34.5, Ktx = 126.7 ± 14.1, C = 72.0 ± 11.0 nM, P < 0.01). (iv) Hypercoagulability markers and natural anticoagulants: The Ktx and ESRD groups showed higher levels of hypercoagulability markers compared to the C group. A reduction in antithrombin activity was evident in ESRD compared to the Ktx group (P = 0.03). (v) Endothelial morphology: The ESRD group showed a thickened vessel basal membrane compared to the Ktx and C groups with more endothelial sufference. (vi) Insulin resistance and pro-inflammatory cytokine profile: The ESRD showed a higher homeostasis model assessment provided equations for estimating insulin resistance (HOMA-IR) compared to the Ktx and C groups (ESRD = 2.6 ± 0.3, Ktx = 1.8 ± 0.2, C = 1.1 ± 0.1, P = 0.005) and increased soluble tumor neurosis factor α (sTNFα) (P < 0.05) and soluble vascular cell adhesion molecule (sVCAM) levels (P < 0.01). Positive correlations were evident among HOMA-IR and sTNFα (P < 0.001) and sVCAM (P = 0.01), respectively. In a small subgroup of ESRD who underwent Ktx (five pts), our findings were confirmed at 1 year of follow-up, suggesting an improvement of almost haemostatic abnormalities. Kidney transplant is associated with a better atherothrombotic profile in ESRD, platelet intracellular calcium and cytokines seem to be most influenced by the transplant, while most morphological abnormalities are retained.",
keywords = "End-stage renal disease, Haemostasis, Kidney transplant, Platelets",
author = "Paolo Fiorina and Franco Folli and Elisabetta Ferrero and Elena Orsenigo and Giovanna Finzi and Gabriella Mazzolari and Claudia Placidi and Lucia Perego and {La Rosa}, Stefano and Marco Melandri and Lucilla Monti and Carlo Capella and Armando D'Angelo and Carlo Staudacher and Antonio Secchi",
year = "2005",
month = "9",
doi = "10.1111/j.1432-2277.2005.00173.x",
language = "English (US)",
volume = "18",
pages = "1036--1047",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients

AU - Fiorina, Paolo

AU - Folli, Franco

AU - Ferrero, Elisabetta

AU - Orsenigo, Elena

AU - Finzi, Giovanna

AU - Mazzolari, Gabriella

AU - Placidi, Claudia

AU - Perego, Lucia

AU - La Rosa, Stefano

AU - Melandri, Marco

AU - Monti, Lucilla

AU - Capella, Carlo

AU - D'Angelo, Armando

AU - Staudacher, Carlo

AU - Secchi, Antonio

PY - 2005/9

Y1 - 2005/9

N2 - End-stage renal disease (ESRD) is characterized by several atherothrombotic abnormalities, and kidney transplant seems to improve most of them. However, because it is not clear which mechanism is responsible for such improvement, our purpose was to clarify that point. We conducted a cross sectional study involving 30 ESRD patients, 30 ESRD kidney-transplanted patients (Ktx) and 30 healthy controls (C) to evaluate platelet morphology and function, atherothrombotic profile, endothelial abnormalities and cytokine levels involved in the insulin resistance/endothelial dysfunction. (i) Platelet morphology: The ESRD group showed platelet size similar to the other two groups (ESRD = 3518 × 103 ± 549 × 103 nm2, C = 3075 × 103 ± 197 × 103 nm2, Ktx = 2862 × 103 ± 205 × 103 nm 2) with similar platelet granules and number. (ii) Platelet surface glycoprotein: The CD41 and P-Selectin were similar between groups. (iii) Platelet intracellular calcium: Resting intracellular calcium was statistically higher in ESRD compared to the C group (ESRD = 182.1 ± 34.5, Ktx = 126.7 ± 14.1, C = 72.0 ± 11.0 nM, P < 0.01). (iv) Hypercoagulability markers and natural anticoagulants: The Ktx and ESRD groups showed higher levels of hypercoagulability markers compared to the C group. A reduction in antithrombin activity was evident in ESRD compared to the Ktx group (P = 0.03). (v) Endothelial morphology: The ESRD group showed a thickened vessel basal membrane compared to the Ktx and C groups with more endothelial sufference. (vi) Insulin resistance and pro-inflammatory cytokine profile: The ESRD showed a higher homeostasis model assessment provided equations for estimating insulin resistance (HOMA-IR) compared to the Ktx and C groups (ESRD = 2.6 ± 0.3, Ktx = 1.8 ± 0.2, C = 1.1 ± 0.1, P = 0.005) and increased soluble tumor neurosis factor α (sTNFα) (P < 0.05) and soluble vascular cell adhesion molecule (sVCAM) levels (P < 0.01). Positive correlations were evident among HOMA-IR and sTNFα (P < 0.001) and sVCAM (P = 0.01), respectively. In a small subgroup of ESRD who underwent Ktx (five pts), our findings were confirmed at 1 year of follow-up, suggesting an improvement of almost haemostatic abnormalities. Kidney transplant is associated with a better atherothrombotic profile in ESRD, platelet intracellular calcium and cytokines seem to be most influenced by the transplant, while most morphological abnormalities are retained.

AB - End-stage renal disease (ESRD) is characterized by several atherothrombotic abnormalities, and kidney transplant seems to improve most of them. However, because it is not clear which mechanism is responsible for such improvement, our purpose was to clarify that point. We conducted a cross sectional study involving 30 ESRD patients, 30 ESRD kidney-transplanted patients (Ktx) and 30 healthy controls (C) to evaluate platelet morphology and function, atherothrombotic profile, endothelial abnormalities and cytokine levels involved in the insulin resistance/endothelial dysfunction. (i) Platelet morphology: The ESRD group showed platelet size similar to the other two groups (ESRD = 3518 × 103 ± 549 × 103 nm2, C = 3075 × 103 ± 197 × 103 nm2, Ktx = 2862 × 103 ± 205 × 103 nm 2) with similar platelet granules and number. (ii) Platelet surface glycoprotein: The CD41 and P-Selectin were similar between groups. (iii) Platelet intracellular calcium: Resting intracellular calcium was statistically higher in ESRD compared to the C group (ESRD = 182.1 ± 34.5, Ktx = 126.7 ± 14.1, C = 72.0 ± 11.0 nM, P < 0.01). (iv) Hypercoagulability markers and natural anticoagulants: The Ktx and ESRD groups showed higher levels of hypercoagulability markers compared to the C group. A reduction in antithrombin activity was evident in ESRD compared to the Ktx group (P = 0.03). (v) Endothelial morphology: The ESRD group showed a thickened vessel basal membrane compared to the Ktx and C groups with more endothelial sufference. (vi) Insulin resistance and pro-inflammatory cytokine profile: The ESRD showed a higher homeostasis model assessment provided equations for estimating insulin resistance (HOMA-IR) compared to the Ktx and C groups (ESRD = 2.6 ± 0.3, Ktx = 1.8 ± 0.2, C = 1.1 ± 0.1, P = 0.005) and increased soluble tumor neurosis factor α (sTNFα) (P < 0.05) and soluble vascular cell adhesion molecule (sVCAM) levels (P < 0.01). Positive correlations were evident among HOMA-IR and sTNFα (P < 0.001) and sVCAM (P = 0.01), respectively. In a small subgroup of ESRD who underwent Ktx (five pts), our findings were confirmed at 1 year of follow-up, suggesting an improvement of almost haemostatic abnormalities. Kidney transplant is associated with a better atherothrombotic profile in ESRD, platelet intracellular calcium and cytokines seem to be most influenced by the transplant, while most morphological abnormalities are retained.

KW - End-stage renal disease

KW - Haemostasis

KW - Kidney transplant

KW - Platelets

UR - http://www.scopus.com/inward/record.url?scp=26944446240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26944446240&partnerID=8YFLogxK

U2 - 10.1111/j.1432-2277.2005.00173.x

DO - 10.1111/j.1432-2277.2005.00173.x

M3 - Article

C2 - 16101724

AN - SCOPUS:26944446240

VL - 18

SP - 1036

EP - 1047

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 9

ER -